Last 7 days
-11.6%
Last 30 days
-45.0%
Last 90 days
-47.2%
Trailing 12 Months
-30.0%
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 4.6% | 1,434,159,000 | 1,370,622,000 | 1,303,740,000 | 1,246,217,000 | 1,167,773,000 |
Operating Expenses | 4.8% | 1,562,798,000 | 1,490,621,000 | 1,431,779,000 | 1,408,100,000 | 1,345,845,000 |
S&GA Expenses | 1.8% | 295,646,000 | 290,499,000 | 290,893,000 | 300,370,000 | 290,991,000 |
EBITDA | -7.5% | -113,525,000 | -105,585,000 | -111,888,000 | -145,503,000 | - |
EBITDA Margin | -2.8% | -0.08 | -0.08 | -0.09 | -0.12 | - |
Earnings Before Taxes | -6.4% | -149,300,000 | -140,311,000 | -146,047,000 | -179,229,000 | -195,286,000 |
EBT Margin | -1.7% | -0.10 | -0.10 | -0.11 | -0.14 | - |
Interest Expenses | 1.9% | 18,289,000 | 17,948,000 | 17,757,000 | 17,596,000 | 17,443,000 |
Net Income | -6.5% | -149,547,000 | -140,478,000 | -146,047,000 | -179,229,000 | -195,286,000 |
Net Income Margin | -1.7% | -0.10 | -0.10 | -0.11 | -0.14 | - |
Free Cahsflow | -161.6% | -45,427,000 | 73,702,000 | -18,504,000 | -54,180,333 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -18.5% | 634 | 778 | 667 | 647 | 631 |
Current Assets | -21.3% | 545 | 692 | 586 | 566 | 553 |
Cash Equivalents | -27.8% | 410 | 567 | 453 | 449 | 467 |
Net PPE | 4.5% | 37.00 | 36.00 | 33.00 | 32.00 | 30.00 |
Goodwill | 0% | 31.00 | 31.00 | 29.00 | - | - |
Liabilities | -21.9% | 395 | 505 | 373 | 353 | 325 |
Current Liabilities | -32.4% | 230 | 340 | 214 | 195 | 167 |
Long Term Debt | 1.1% | 154 | 152 | 151 | - | - |
LT Debt, Current | NaN% | - | - | - | - | - |
LT Debt, Non Current | 0.1% | 161 | 161 | 154 | 152 | 151 |
Shareholder's Equity | -12.5% | 238 | 272 | 294 | 293 | 306 |
Retained Earnings | -8.4% | -732 | -675 | -635 | -623 | -582 |
Additional Paid-In Capital | 2.4% | 970 | 947 | 929 | 917 | 889 |
Accumulated Depreciation | 4.5% | 96.00 | 92.00 | 88.00 | - | - |
Shares Outstanding | 0.0% | 187 | 187 | 187 | 187 | 187 |
Minority Interest | Infinity% | 1.00 | - | - | 0.00 | 0.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -161.6% | -45.43 | 74.00 | -18.50 | -52.31 | -78.78 |
Share Based Compensation | -6.8% | 82.00 | 88.00 | 99.00 | 118 | 122 |
Cashflow From Investing | -22.4% | -28.22 | -23.06 | -21.93 | -22.50 | -20.81 |
Cashflow From Financing | -3.1% | 17.00 | 17.00 | -0.10 | -3.53 | 360 |
Buy Backs | NaN% | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
93.3%
79.8%
57.7%
Y-axis is the maximum loss one would have experienced if Alignment Healthcare was unfortunately bought at previous high price.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 74.58 | 232,862 | 550,862 | -% |
2023-02-28 | Voya Investment Management LLC | added | 720 | 2,764,000 | 3,150,000 | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -42.17 | -1,978,000 | 2,669,000 | -% |
2023-02-17 | Coppell Advisory Solutions Corp. | new | - | 706 | 706 | -% |
2023-02-15 | Metropolitan Life Insurance Co/NY | added | 12.11 | 7,724 | 72,724 | -% |
2023-02-15 | ALLIANCEBERNSTEIN L.P. | reduced | -55.88 | -2,324,470 | 1,813,530 | -% |
2023-02-15 | MetLife Investment Management, LLC | added | 14.15 | 72,683 | 616,683 | -% |
2023-02-15 | State of Wyoming | reduced | -5.1 | -6,194 | 103,806 | 0.04% |
2023-02-15 | JANE STREET GROUP, LLC | reduced | -22.76 | -517,329 | 1,704,670 | -% |
2023-02-15 | Regal Partners Ltd | sold off | -100 | -187,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | general atlantic, l.p. | 32.6% | 60,993,323 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 14, 2022 | warburg pincus private equity xii, l.p. | 7.8% | 14,665,604 | SC 13G | |
Feb 11, 2022 | general atlantic, l.p. | 37.4% | 70,069,317 | SC 13G | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 1.13 -81.20% | 2.14 -64.39% | 3.92 -34.78% | 6.25 3.99% | 8.65 43.93% |
Current Inflation | 1.06 -82.36% | 1.97 -67.22% | 3.53 -41.26% | 5.55 -7.65% | 7.63 26.96% |
Very High Inflation | 0.97 -83.86% | 1.76 -70.72% | 3.06 -49.08% | 4.73 -21.30% | 6.43 6.99% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-14 | Freeman Robert Thomas | sold | -85,224 | 6.327 | -13,470 | chief financial officer |
2023-03-14 | Maroney Dawn Christine | sold | -126,578 | 6.327 | -20,006 | president, markets |
2023-03-14 | KAO JOHN E | sold | -247,392 | 6.327 | -39,101 | chief executive officer |
2023-03-14 | Maroney Dawn Christine | gifted | - | - | -2,400 | president, markets |
2023-03-14 | Kumar Dinesh M. | sold | -89,615 | 6.327 | -14,164 | chief med & operating officer |
2023-03-14 | Cross Richard A. | sold | -34,899 | 6.327 | -5,516 | svp, general counsel |
2023-03-09 | KONOWIECKI JOSEPH S | bought | 661,610 | 6.6161 | 100,000 | chairman of the board |
2023-03-08 | KOSECOFF JACQUELINE B | acquired | - | - | 29,070 | - |
2023-03-08 | McCarthy Margaret M | acquired | - | - | 21,802 | - |
2023-03-08 | BILNEY JODY L | acquired | - | - | 29,070 | - |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues: | |||
Earned premiums | $ 1,431,550 | $ 1,167,085 | $ 955,393 |
Other | 2,609 | 688 | 3,829 |
Total revenues | $ 1,434,159 | $ 1,167,773 | $ 959,222 |
Revenue, Product and Service [Extensible List] | us-gaap:FinancialServiceMember | us-gaap:FinancialServiceMember | us-gaap:FinancialServiceMember |
Expenses: | |||
Medical expenses | $ 1,249,879 | $ 1,039,041 | $ 792,992 |
Selling, general, and administrative expenses | 295,646 | 290,991 | 156,398 |
Depreciation and amortization | 17,273 | 15,813 | 15,095 |
Total expenses | 1,562,798 | 1,345,845 | 964,485 |
Loss from operations | (128,639) | (178,072) | (5,263) |
Other expenses: | |||
Interest expense | 18,289 | 17,443 | 16,931 |
Other expenses (income) | 176 | (229) | 732 |
Loss on extinguishment of debt | 2,196 | 0 | 0 |
Total other expenses | 20,661 | 17,214 | 17,663 |
Loss before income taxes | (149,300) | (195,286) | (22,926) |
Provision for income taxes | 339 | 0 | 0 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total | (149,639) | (195,286) | (22,926) |
Less: Net loss attributable to noncontrolling interest | 92 | 0 | 0 |
Net loss attributable to Alignment Healthcare, Inc. | $ (149,547) | $ (195,286) | $ (22,926) |
Total weighted-average common shares outstanding - basic and diluted | 181,212,757 | 171,956,849 | 152,132,299 |
Net loss per share attributable to Alignment Healthcare, Inc. - basic | $ (0.83) | $ (1.14) | $ (0.15) |
Net loss per share attributable to Alignment Healthcare, Inc. - diluted | $ (0.83) | $ (1.14) | $ (0.15) |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |||
---|---|---|---|---|---|---|
Current Assets: | ||||||
Cash | $ 409,549 | $ 466,600 | ||||
Accounts receivable (less allowance for credit losses of $0 at December 31, 2022 and $111 at December 31, 2021, respectively) | 92,890 | 58,512 | ||||
Prepaid expenses and other current assets | 42,107 | 27,747 | ||||
Total current assets | 544,546 | 552,859 | ||||
Property and equipment, net | 37,169 | 30,358 | ||||
Right of use asset, net | 5,825 | 7,853 | ||||
Goodwill and intangible assets, net | 40,288 | 35,116 | ||||
Other assets | 6,035 | 4,709 | ||||
Total assets | 633,863 | 630,895 | ||||
Current Liabilities: | ||||||
Medical expenses payable | 170,135 | 125,886 | ||||
Accounts payable and accrued expenses | 32,288 | 17,431 | ||||
Accrued compensation | 27,538 | 23,928 | ||||
Total current liabilities | 229,961 | 167,245 | ||||
Long-term debt, net of debt issuance costs | 160,902 | 150,620 | ||||
Long-term portion of lease liabilities | 3,698 | 6,975 | ||||
Total liabilities | 394,561 | 324,840 | ||||
Commitments and Contingencies (Note 12) | ||||||
Stockholders' Equity: | ||||||
Preferred stock, $.001 par value; 100,000,000 and 100,000,000 shares authorized as of December 31, 2022 and December 31, 2021, respectively; no shares issued and outstanding as of December 31, 2022 and December 31, 2021 | 0 | 0 | ||||
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2022 and December 31, 2021; 187,280,015 and 187,193,613 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively | 187 | 187 | ||||
Additional paid-in capital | 970,180 | 888,547 | ||||
Accumulated deficit | (732,241) | (582,694) | ||||
Total Alignment Healthcare, Inc. stockholders' equity | 238,126 | 306,040 | ||||
Noncontrolling interest | 1,176 | 15 | ||||
Total stockholders' equity | 239,302 | 306,055 | $ 30,611 | [1] | ||
Total liabilities and stockholders' equity | $ 633,863 | $ 630,895 | ||||
|